Risk Intelligence
Margin pressure from CPVC mix shift
View Risks →Platinum Industries reported Q3 FY26 standalone revenue of ₹102.62 crore, up 31% YoY, driven by strong CPVC demand and capacity expansion.
✓ Verified against BSE filing
Platinum Industries reported Q3 FY26 standalone revenue of ₹102.62 crore, up 31% YoY, driven by strong CPVC demand and capacity expansion. PAT grew 18% YoY to ₹12.93 crore, though EBITDA margin contracted to 15.8% due to higher CPVC mix and new plant costs. Management guided for >40% revenue growth in FY27 and a 35% CAGR through FY29, supported by the Palar facility ramp-up (CPVC at 60-65% utilization) and Egypt plant commissioning by September 2026. The company also entered pharma via a new subsidiary. Risks include margin pressure from product mix shift and execution delays in Egypt.
Margin pressure from CPVC mix shift
View Risks →Full transcript text is available on this route.
Read Transcript →12,000 ton CPVC plant at Palar running at 60-65% utilization as of Q3.
Egypt facility will have 60,000 tons total capacity; commercial production expected by September 2026.
India capacity doubled from 30,000 to 60,000 metric tons over last 2-3 years.
Management targets 50% utilization of Egypt's 600 crore potential within 3 years.
Management expects standalone revenue growth exceeding 40% in FY27, driven by Palar ramp-up and Egypt commissioning.
Higher CPVC sales, which carry lower margins, have compressed overall EBITDA margins from 23% in FY24 to ~15% currently.
View Risks →